Economic TimesLean R·
New norms for faster drug rollout proposed
New Delhi: The government is looking to simplify the regulatory process for bioavailability and bioequivalence (BA/BE) studies for domestic drug approvals, allowing applicants to start eligible studies after intimating the drug regulator instead of requiring its prior permission.The proposal has been placed for deliberation before the Drugs Technical Advisory Board (DTAB) slated to happen this month, people familiar with the matter told ET.Also read: New TB vaccines expected from 2029 could pre…
Read at Economic Times →
